Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations (Tables)

v3.21.2
Discontinued Operations (Tables)
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities Included as Discontinued Operations and Income (Loss) from Discontinued Operations

The following table summarizes the carrying amounts of the assets and liabilities included as discontinued operations in the condensed balance sheet at December 31, 2020 (in thousands):

 

 

December 31,

 

 

 

 

2020

 

 

Assets of discontinued operations

 

 

 

 

 

Accounts receivable, net

 

$

214

 

 

Inventories

 

 

1,341

 

 

Prepaid expenses and other current assets

 

 

158

 

 

Property and equipment, net

 

 

684

 

 

Other long-term assets

 

 

78

 

 

Total assets of discontinued operations

 

$

2,475

 

 

 

 

 

 

 

 

Liabilities of discontinued operations

 

 

 

 

 

Accounts payable

 

$

100

 

 

Accrued expenses

 

 

201

 

 

Deferred revenue

 

 

2,487

 

 

Total liabilities of discontinued operations

 

$

2,788

 

 

The following table summarizes the major classes of items constituting income (loss) from discontinued operations in the condensed statements of operations for each of the periods presented (in thousands):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product sales

 

$

140

 

 

$

118

 

 

$

852

 

 

$

670

 

Service and other

 

 

349

 

 

 

729

 

 

 

1,748

 

 

 

2,259

 

Total net revenues

 

 

489

 

 

 

847

 

 

 

2,600

 

 

 

2,929

 

Cost of revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product sales

 

 

158

 

 

 

347

 

 

 

1,201

 

 

 

1,127

 

Service and other

 

 

238

 

 

 

504

 

 

 

1,089

 

 

 

1,296

 

Total cost of revenues

 

 

396

 

 

 

851

 

 

 

2,290

 

 

 

2,423

 

Gross income (loss)

 

 

93

 

 

 

(4

)

 

 

310

 

 

 

506

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   Selling, general and administrative

 

 

330

 

 

 

236

 

 

 

1,110

 

 

 

958

 

   Research and development

 

 

134

 

 

 

21

 

 

 

388

 

 

 

47

 

Total operating expenses

 

 

464

 

 

 

257

 

 

 

1,498

 

 

 

1,005

 

Operating loss

 

 

(371

)

 

 

(261

)

 

 

(1,188

)

 

 

(499

)

Interest expense, net

 

 

(22

)

 

 

(3

)

 

 

(94

)

 

 

(24

)

Loss from discontinued operations

 

 

(393

)

 

 

(264

)

 

 

(1,282

)

 

 

(523

)

Gain on sale of the Dermatology Business

 

 

3,473

 

 

 

 

 

 

3,473

 

 

 

 

Income (loss) from discontinued operations

 

$

3,080

 

 

$

(264

)

 

$

2,191

 

 

$

(523

)